Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Other Operating Expenses (2020 - 2025)

Cresco Labs filings provide 6 years of Other Operating Expenses readings, the most recent being $101.9 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 3212.84% to $101.9 million in Q4 2025 year-over-year; TTM through Mar 2026 was $100.9 million, a 261.47% increase, with the full-year FY2025 number at $105.1 million, up 269.71% from a year prior.
  • Other Operating Expenses hit $101.9 million in Q4 2025 for Cresco Labs, up from -$152000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $101.9 million in Q4 2025 to a low of -$59.5 million in Q2 2024.
  • Median Other Operating Expenses over the past 5 years was $66000.0 (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Other Operating Expenses: crashed 14902.99% in 2024 and later skyrocketed 3212.84% in 2025.
  • Cresco Labs' Other Operating Expenses stood at $10.9 million in 2021, then grew by 21.65% to $13.3 million in 2022, then tumbled by 99.62% to $50000.0 in 2023, then crashed by 6644.0% to -$3.3 million in 2024, then skyrocketed by 3212.84% to $101.9 million in 2025.
  • The last three reported values for Other Operating Expenses were $101.9 million (Q4 2025), -$152000.0 (Q3 2025), and -$836000.0 (Q2 2025) per Business Quant data.